The Meaning of Lymphadenopathies During Adjuvant Durvalumab After Chemoradiotherapy for Lung Cancer: Thinking Beyond Disease Progression
AuthID
P-00W-ZG9
P-00W-ZG9
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service